Stay updated with breaking news from Roche low code enablement application platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Roche Low Code Enablement Application Platform Today - Breaking & Trending Today
SOUTH SAN FRANCISCO (dpa-AFX) - Jnana Therapeutics, a privately held company focused on chemo-proteomics platform, said on Tuesday that it has inked a collaboration and license deal with Roche ....
So this was a global stud they looked at about 1,900 patients given a subcutaneous injection of a drug called, say this, gantaneraclav, tackles amyloids in the brain and tries to remove them. it didn t show significant reduction in cognitive decline and also did not show promise in terms of amount of amalloyd able to remove from the brain. disappointing, roche, drugmaker expressed disate appointment and hope it adds data to the field which we see a lot of setbacks in terms of these alzheimer s drugs. i m wondering and so many at home, why is it so hard to find an effective treatment for alzheimer s? seems to be the one that s hardest? it really is and haven t had a new drug until 2003. even that was surrounded with ....
An experimental Alzheimer s drug failed to slow cognitive decline in a long-awaited trial, marking the latest disappointment in a research field that has been wrought with setbacks. ....